American Society of Clinical Oncology

SHERPA: White

People

  1. Rusch
    Rusch
  2. Kris
    Kris
  3. Zauderer
    Zauderer
  4. Ladanyi
    Ladanyi
  5. Riely
    Riely
  6. Adusumilli
    Adusumilli
  7. Chaft
    Chaft
  8. Miller
    Miller
  9. Park
    Park
  10. Downey
    Downey

Groups

  1. Department of Medicine (44)
  2. Solid Tumor Oncology Division (44)
  3. Surgery (44)
  4. Thoracic Oncology (44)
  5. Epidemiology and Biostatistics (17)
  6. Biostatistics Service (16)
  7. GSK Faculty (16)
  8. Tow Center for Developmental Oncology (TCDO) (14)
  9. Human Oncology and Pathogenesis Program (12)
  10. Survivorship Research (11)
Search Within
  1. "Valerie Rusch"
  2. "Thoracic Oncology"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (8)
Groups
  1. Department of Medicine (44)
  2. Solid Tumor Oncology Division (44)
  3. Surgery (44)
  4. Thoracic Oncology (44)
  5. Epidemiology and Biostatistics (17)
  6. Biostatistics Service (16)

More Groups

People
  1. Valerie Rusch (44)
  2. Mark Kris (28)
  3. Marc Ladanyi (12)
  4. Marjorie Zauderer (12)
  5. Lee Krug (11)
  6. Andreas Rimner (9)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (6)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (43)
  2. JCO Precision Oncology (1)

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers
    Meeting Abstract

    Sepesi, B.; Jones, D. R.; Meyers, B. F.; Chaft, J. E.; Sholl, L. M.; Shyr, Y.; Kelly, K.; Lin, J.; Bunn, P. A.; Minna, J. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy
    Meeting Abstract

    Offin, M.; Egger, J. V.; McCarthy, C. G.; Rudneva, V.; Beattie, J.; Ginsberg, M. S.; Sauter, J. L.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006)
    Meeting Abstract

    Rimner, A.; Zauderer, M. G.; Yorke, E.; Simone, C. B.; Gill, R. R.; Voong, K. R.; Peikert, T.; Tsao, M. S.; Li, Z.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Rizvi, H.; DuBoff, M. A.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ladanyi, M.; Rimner, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3)
    Meeting Abstract

    Kwiatkowski, D. J.; Rusch, V. W.; Chaft, J. E.; Johnson, B. E.; Nicholas, A.; Wistuba, I. I.; Merritt, R.; Lee, J. M.; Bunn, P. A.; Tang, Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers
    Meeting Abstract

    Haseltine, J.; Offin, M.; Myers, M. L.; Makhnin, A.; Adamski, A.; Li, H.; Li, M.; Shaffer, T.; Henderson, S.; Shen, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial
    Meeting Abstract

    Oezkan, F.; He, K.; Owen, D. H.; Pietrzak, M.; Rusch, V. W.; Chaft, J. E.; Kitzler, R.; Nicholas, A.; Schulze, K.; Johnson, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • SELECT: A phase II trial of adjuvant erlotinib in patients with resected epidermal growth factor receptor-mutant non-small-cell lung cancer
    Journal Article

    Pennell, N. A.; Neal, J. W.; Chaft, J. E.; Azzoli, C. G.; Jänne, P. A.; Govindan, R.; Evans, T. L.; Costa, D. B.; Wakelee, H. A.; Heist, R. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save